Wambolt & Associates, LLC Abbott Laboratories Transaction History

Wambolt & Associates, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $186,745 - $208,073	1,853 New	1,853 $202,000
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $10,456 - $12,267	-110 Reduced 4.22%	2,499 $274,000
Q3 2022 Oct 18, 2022	SELL	$96.76 - $112.03 $3,870 - $4,481	-40 Reduced 1.51%	2,609 $252,000
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $6,430 - $7,772	-63 Reduced 2.32%	2,649 $288,000
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $4,902 - $5,978	43 Added 1.61%	2,712 $322,000
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $231 - $282	-2 Reduced 0.07%	2,669 $376,000
Q3 2021 Oct 20, 2021	BUY	$116.66 - $129.06 $6,066 - $6,711	52 Added 1.99%	2,671 $313,000
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $79,342 - $93,397	750 Added 40.13%	2,619 $307,000
Q1 2021 Apr 19, 2021	BUY	$108.84 - $128.23 $2,176 - $2,564	20 Added 1.08%	1,869 $222,000
Q4 2020 Jan 19, 2021	SELL	$105.0 - $114.42 $88,935 - $96,913	-847 Reduced 31.42%	1,849 $202,000
Q3 2020 Nov 04, 2020	BUY	$91.64 - $111.29 $247,061 - $300,037	2,696 New	2,696 $293,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Wambolt & Associates, LLC with notifications on news.